For patients with hormone receptor positive breast cancer

There are three different receptors that are commonly found in breast cancer cells: the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2). When the hormones estrogen and progesterone attach to their receptors, they are activated and fuel cancer growth. Active HER-2 also fuels cancer growth.

For patients with triple negative breast cancer (TNBC)

Triple negative breast cancer represents 10% to 15% of all breast cancers. A TNBC diagnosis means that the cancer cells have tested negative for the 3 different receptors that are commonly found on breast cancer cells: the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2).

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Explore breast cancer clinical trials that are enrolling volunteers

Below is a list of all available breast cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can also sort results to show trials nearest to you by entering your city or postal code in the search field.

Resources for patients

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.
Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.
Learn more